Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth ; volume:13 ; number:1 ; day:16 ; month:8 ; year:2022 ; pages:1-12 ; date:12.2022
Nature Communications ; 13, Heft 1 (16.8.2022), 1-12, 12.2022
- Creator
-
Wang, Xiaolei
Vincent, Eunice
Siddiqui, Summer
Turnbull, Katherine
Lu, Hong
Blair, Robert
Wu, Xueling
Watkins, Meagan
Ziani, Widade
Shao, Jiasheng
Doyle-Meyers, Lara A.
Russell-Lodrigue, Kasi E.
Bohm, Rudolf P.
Veazey, Ronald S.
Xu, Huanbin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-32554-z
- URN
-
urn:nbn:de:101:1-2022110322292782398444
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Xiaolei
- Vincent, Eunice
- Siddiqui, Summer
- Turnbull, Katherine
- Lu, Hong
- Blair, Robert
- Wu, Xueling
- Watkins, Meagan
- Ziani, Widade
- Shao, Jiasheng
- Doyle-Meyers, Lara A.
- Russell-Lodrigue, Kasi E.
- Bohm, Rudolf P.
- Veazey, Ronald S.
- Xu, Huanbin
- SpringerLink (Online service)
Other Objects (12)
Increased neutrophil apoptosis in chronically SIV-infected macaques
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
No evidence for ongoing replication on ART in SIV-infected macaques
A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
Prolonged AIDS-free Survival for SIV-infected Macaques Treated With Anti-FasL
The role of MHC class I gene products in SIV infection of macaques
Brain 18F-FDG PET of SIV-infected macaques after treatment interruption or initiation
Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
Increased neutrophil apoptosis in chronically SIV-infected macaques
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
No evidence for ongoing replication on ART in SIV-infected macaques
A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
Prolonged AIDS-free Survival for SIV-infected Macaques Treated With Anti-FasL
The role of MHC class I gene products in SIV infection of macaques
Brain 18F-FDG PET of SIV-infected macaques after treatment interruption or initiation
Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
Increased neutrophil apoptosis in chronically SIV-infected macaques
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
No evidence for ongoing replication on ART in SIV-infected macaques
A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
Prolonged AIDS-free Survival for SIV-infected Macaques Treated With Anti-FasL
The role of MHC class I gene products in SIV infection of macaques
Brain 18F-FDG PET of SIV-infected macaques after treatment interruption or initiation
Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells